The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML ...

Symptoms of non-Hodgkin's lymphoma may include painless swelling ... See what to expect with chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, and learn how it's treated.

Blood cancer is not always fatal and advancements in treatment offer significant hope. Misconceptions exist, such as it being ...

Discover important insights into the clonal evolution of blastic plasmacytoid dendritic cell neoplasm, a rare and aggressive ...

Many more blood cancer patients are living five years after diagnosis as treatment improves, with the rate now at 67% of ...

(HealthDay News) — Overall survival (OS) after umbilical cord blood transplant (UCBT) has improved over time, according to a study published in Transplantation and Cellular Therapy.

July 22, 2024 — The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for ...

New report highlights variance in blood cancer types, with Hodgkin lymphoma having the highest five-year net survival ...

Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best ...

An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial.

NMT2 expression was identified as a marker for Acute Myeloid Leukemia (AML ... small-molecule NMTi being developed to treat patients with leukemia, lymphoma, and for the treatment of solid tumors when ...

People who develop blood cancers in Ireland now have increased chance of survival due to better diagnosis and treatment, according to a new report.